What is Emeticon used for?

Emeticon is indicated for Postoperative nausea and vomiting.

What development phase is Emeticon in?

Emeticon is FDA-approved (marketed).

What is the generic name of Emeticon?

BENZQUINAMIDE is the generic (nonproprietary) name of Emeticon.

Last reviewed 2026-04-20 · How we verify

Emeticon (BENZQUINAMIDE)

FDA-approved approved Small molecule Quality 25/100

Emeticon (BENZQUINAMIDE) is a small molecule drug that targets Prostaglandin G/H synthase 2. It was originally developed and is currently owned by a company not specified in the facts. Emeticon was FDA approved in 1974 for the treatment of postoperative nausea and vomiting. It is classified as a benzquinamide and is off-patent, meaning it is no longer protected by patents. Emeticon has a bioavailability of 36%.

At a glance

Generic name	BENZQUINAMIDE
Drug class	benzquinamide
Target	Prostaglandin G/H synthase 2
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved
First approval	1974

Approved indications

Postoperative nausea and vomiting

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions